Summary
From 6/79 until 2/86, 9 patients (median age 39) with Burkitt's lymphoma were treated. Stage D disease was seen in 7 cases, stage C in two and stage A in one. The main symptom was abdominal pain or a rapidly progressing abdominal tumor. Three patients had bone marrow involvement and two had a Burkitt's leukemia. Three had typical chromosomal aberrations. Therapy consisted of a variety of chemotherapy regimens plus additional radiotherapy and/or bulk surgery. Two patients achieved complete remissions (of 6 and 20+ months duration), and 4 partial remissions were obtained. The remaining patients had either progressive, drug resistant disease or died early. One patient is currently alive and in complete remission at 20+ months. A second patient is alive at 20+ months in partial remission with traces of IgM-paraprotein still detectable. The main causes of death were tumor-lysis syndrom (4 patients) and therapy related sepsis with progressive tumor (3 patients). This poor outcome is probably due to a high proportion of high-risk patients and suboptimal therapy for this rapidly proliferating tumor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berger R, Bernheim A (1982) Cytogenetic studies on Burkitt's lymphoma-leukemia. Cancer Genet Cytogenet 7: 231–244
Bird AG, Britton S (1982) The relationship between Epstein-Barr virus and lymphoma. Sem in Hematol 19: 285–300
Cohen LF, Balow JE, Magrath IT (1980) Acute tumor lysis syndrom: a review of 37 patients with Burkitt's lymphoma. Am J Med 68: 486–491
Dalla-Favera R, Bregni M, Erikson J (1982) Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 79: 7824–7827
Klein G (1975) The Epstein-Barr virus and neoplasia. N Engl J Med 293: 1353–1357
Klein G, Klein E (1985) Evolution of tumors and the impact of molecular oncology. Nature 315: 190–196
Levine PH, Kamaraju LS, Conelly RR (1982) The American Burkitt's Lymphoma Registry: eight years experience. Cancer 49: 1016–1021
Magrath IT, Lee YJ, Anderson T (1980) Prognostic factors in Burkitt's lymphoma: importance of total tumor burden. Cancer 45: 1507–1515
Magrath IT, Janus C, Edwards B (1984) An effective therapy for both undifferentiated (including Burkitt's) lymphoma and lymphoblastic lymphomas in children and young adults. Blood 63: 1102–1111
Müller-Weihrich S, Beck J, Henze G (1984) BFM study 1981/83 for treatment of highly malignant non-Hodgkin's lymphomas in children: results of a therapeutic regimen stratified according to histologic-immunologic type and clinical stage. Klin Paediatr 196: 135–142
Pees HW, Riehm HJ, Schwamborn J (1985) Effective treatment of Burkitt's type and B-ALL in adults. Blut 50: 213–218
Steinke B, Gärtner HV, Ostendorf P, Waller HD (1984) Klinik und Therapie des malignen Lymphoms vom Burkitt-Typ bei Erwachsenen. Eine Übersicht anhand von 14 Fällen. Tumor Diagnostik und Therapie 5: 1–6
Zhang S, Zech L, Klein G (1982) High-resolution analysis of chromosome markers in Burkitt lymphoma cell lines. Int J Cancer 29: 153–157
Ziegler JL (1977) Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N Engl J Med 297: 75–80
Ziegler JL, Magrath IT, Olweny CLM (1979) Cure of Burkitt's lymphoma: ten year follow up of 137 Uganden patients. Lancet 2: 936–938
Ziegler JL (1981) Burkitt's lymphoma. N Engl J Med 305: 735–745
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anger, B., Bunjes, D., Carbonell, F. et al. Treatment results of nine patients with burkitt's lymphoma. Blut 53, 279–286 (1986). https://doi.org/10.1007/BF00320885
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320885